BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15490468)

  • 1. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): preliminary analysis of the ongoing workforce survey.
    Deubner DC; Goodman M; Iannuzzi J
    Appl Occup Environ Hyg; 2001 May; 16(5):521-6. PubMed ID: 11370932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
    Maier LA
    Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.
    Hines SE; Pacheco K; Maier LA
    Curr Opin Allergy Clin Immunol; 2012 Apr; 12(2):102-10. PubMed ID: 22306552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beryllium--underestimated occupational health hazard in Poland].
    Dudek W; Walusiak J; Wittczak T
    Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC; Fink J; Kowalski PJ; Lewin MD; Sinks T
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BeLPT: algorithms and implications.
    Middleton DC; Lewin MD; Kowalski PJ; Cox SS; Kleinbaum D
    Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric test for beryllium sensitivity.
    Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
    Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease.
    Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of chronic berylliosis].
    Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
    Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beryllium BioBank: 2. Lymphocyte proliferation testing.
    Harber P; Su J; Alongi G
    J Occup Environ Med; 2014 Aug; 56(8):857-60. PubMed ID: 25099413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT.
    Farris GM; Newman LS; Frome EL; Shou Y; Barker E; Habbersett RC; Maier L; Smith HN; Marrone BL
    Toxicology; 2000 Feb; 143(2):125-40. PubMed ID: 10755700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rocky Flats Beryllium Health Surveillance.
    Stange AW; Furman FJ; Hilmas DE
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.